All In MedTech

Device Trial Radar · NCT05323448

Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.

Last checked: Nov 20, 2026Latest source record: Apr 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

91

Actual

Start

Oct 25, 2022

Primary completion

Mar 9, 2025

Study completion Jul 1, 2025

Sponsor

Lead sponsor
Polyclinique Bordeaux Nord AquitaineAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Bard Ltd
First posted
Apr 12, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to assess the efficacy of the ARISTA AH for restoring hemostasis following a long segment posterior spinal fusion.

Conditions

  • Hemostatics
  • Hemostasis
  • Spinal Deformity
  • Spinal Fusion

Interventions

  • Control GroupDevice

    During the surgical procedure, hemostasis will be achieved using the standard of care (electrocautery, pressure, ligature or any hemostatic agent).

  • ARISTADevice

    During the surgical procedure, hemostasis will be achieved using the standard of care (electrocautery, pressure, ligature or any hemostatic agent). Before surgical wound closure, the corresponding amount of ARISTA-AH will be applied to completely cover the bleeding site : * 5g for 5 to 8 instrumented vertebra * 10g fo 9 or more instrumented vertebra

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blood loss within the first 24 hours after posterior spinal fusionTime frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Polyclinique Bordeaux Nord Aquitaine

    Bordeaux, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.